Innovive Pharmaceuticals, Inc.·4

Jul 12, 4:46 PM ET

Innovive Pharmaceuticals, Inc. 4

4 · Innovive Pharmaceuticals, Inc. · Filed Jul 12, 2007

Insider Transaction Report

Form 4
Period: 2007-07-10
Poma Eric E
VP - Business Development
Transactions
  • Award

    Stock Option (Right to Buy)

    2007-07-10+37,50037,500 total
    Exercise: $4.00Exp: 2017-07-10Common Stock (37,500 underlying)
  • Award

    Stock Option (Right to Buy

    2007-07-10+37,50037,500 total
    Exercise: $5.00Exp: 2017-07-10Common Stock (37,500 underlying)
Holdings
  • Common Stock

    63,160
  • Stock Option (Right to Buy)

    Exercise: $3.96Exp: 2016-08-08Common Stock (60,000 underlying)
    60,000
Footnotes (2)
  • [F1]Option vests in three equal annual installments beginning on August 8, 2007.
  • [F2]Option vests in three equal annual installments beginning on July 10, 2008.

Documents

1 file
  • 4
    rrd165787.xmlPrimary

    STOCK OPTION GRANT